<DOC>
	<DOCNO>NCT00662090</DOCNO>
	<brief_summary>The aim study improve accuracy diagnosis child adolescent MDS standardize review morphology standardize cytogenetic molecular analysis . The primary objective study : - To evaluate frequency different subtypes MDS childhood adolescence standardize diagnostic approach - To evaluate frequency cytogenetic molecular abnormality : Specifically use array-CGH evaluate frequency subtle chromosomal imbalance , i.e . gain loss define chromosomal region , amplification . Specifically use mFISH identify unknown chromosomal aberration , particularly subtle translocation involve new candidate gene , good define chromosomal breakpoints . The secondary objective study : - To assess survival child adolescent MDS JMML - To evaluate relapse rate , morbidity mortality child MDS JMML treat HSCT</brief_summary>
	<brief_title>Study Epidemiology Characterization Myelodysplastic Syndromes ( MDS ) Juvenile Myelomonocytic Leucemia ( JMML ) Childhood</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Acute</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Chronic</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Juvenile</mesh_term>
	<criteria>Written inform consent caretaker whenever possible patient 's assent . Confirmed diagnosis MDS JMML ( morphology , cytogenetics ) Myeloid leukemia Down syndrome ( patient age &gt; 6 year ) . Age le 18 year Denied informed consent and/or assent caretakers/patient . Myeloid leukemia Down syndrome ( patient &lt; 6 year ) . Participation another study within last 4 week ( except therapy optimize study cancer bone marrow failure disorder study diagnostics ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>215 Months</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>MDS</keyword>
	<keyword>JMML</keyword>
	<keyword>EWOG-MDS</keyword>
	<keyword>Myelodysplastic Syndromes ( MDS )</keyword>
	<keyword>Juvenile Myelomonocytic Leukemia ( JMML )</keyword>
</DOC>